Breaking News

Evotec, U.S. EPA in Compound Tox Pact

Five-year contract valued at $10 million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has entered into a five-year compound management agreement with the U.S. EPA. The contract has a total value of as much as $10 million. Evotec, through its San Francisco operations, will provide chemical procurement, analysis, sample preparation, and management services to support the EPA’s National Computational Center for Toxicology (NCCT). Services provided will support bioactivity profiling of the EPA’s ToxCast (Prioritization of Environmentally Relevant Chemicals) Compound Librar...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters